Bristol-Myers Squibb Company is a global biopharmaceutical company focused on discovering, developing, licensing, manufacturing, and commercializing medicines for serious diseases. Bristol-Myers Squibb Company’s portfolio spans oncology, hematology, immunology, cardiovascular disease, and neuroscience, with products that include small-molecule drugs, biologics, and CAR-T cell therapies. The company serves patients and healthcare providers worldwide through branded therapies and specialty medicines used in complex treatment settings. Bristol-Myers Squibb Company also supports ongoing research and development across multiple therapeutic areas, combining scientific expertise with large-scale manufacturing and distribution capabilities. Headquartered in Princeton, New Jersey, and founded in 1933, Bristol-Myers Squibb Company remains a major participant in the global pharmaceutical market, known for advancing treatments aimed at addressing high-need medical conditions.